http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_715bee03597d4b1f73a7c1d80113d6e2
Outgoing Links
Predicate | Object |
---|---|
family-name | Wilkinson |
name | Barrie Wilkinson |
given-name | Barrie |
organization-name | Biotica, Chesterford Research Park, Little Chesterford, Essex, United Kingdom. Department of Molecular Microbiology, John Innes Centre, Norwich, NR4 7UH, UK Contribution from the Department of Chemistry, Box 351700, University of Washington, Seattle, Washington 98195-1700 Biotica Technology Ltd., Chesterford Research Park, Cambridge, CB10 1XL, United Kingdom Financial Services, Oliver Wyman, London, UK W1U 8EW Biotica Technology Ltd, Chesterford Research Park, Little Chesterford, Saffron Walden, Essex CB10 1XL, UK Biotica Technology Ltd., Chesterford Research Park, Cambridge, United Kingdom A. F. A. Marsden, J. Cortés, N. J. Dunster, P. F. Leadlay, Cambridge Centre for Molecular Recognition and Department of Biochemistry, University of Cambridge, Tennis Court Road, Cambridge, CB2 1QW, UK.; B. Wilkinson and J. Staunton, Cambridge Centre for Molecular Recognition and University Chemical Laboratory, University of Cambridge, Lensfield Road, Cambridge, CB2 1EW, UK. Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, NR4 7UH, UK Biotica Technology Limited, Chesterford Research Park, Essex, CB10 1XL, U.K. Dow AgroSciences, Indianapolis, Indiana, and Department of Biochemistry, University of Cambridge, Cambridge CB2 1GA, U.K. Bioprocessing Research Unit, GlaxoWellcome Research and Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire, SG1 2NY, UK. Email: bw37730@glaxowellcome.co.uk Biotica Technology Ltd., Cambridge CB21 6AD, United Kingdom;; Isomerase Therapeutics Ltd., Cambridge CB10 1XL, United Kingdom; Biotica Technology Limited, Chesterford Research Park, Nr. Saffron Walden, Essex CB10 1XL, United Kingdom, Section of Structural Biology, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, United Kingdom, CompChem Solutions, St. John’s Innovation Centre, Cowley Road, Cambridge CB4 0WS, United Kingdom Department of Molecular Microbiology; John Innes Centre; Norwich; UK Department of Molecular Microbiology; John Innes Centre; Norwich; UK; Isomerase Therapeutics Ltd Biotica Technology Limited, Chesterford Research Park, CB10 1XL Essex, United Kingdom Biotica Technology Ltd, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, UK. barrie.wilkinson@biotica.com Contribution from the School of Chemistry and Department of Biomolecular Sciences, The University of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom, and Biotica, Chesterford Research Park, Little Chesterford, Essex CB10 1XL, United Kingdom Department of Molecular Microbiology, John Innes Centre, Norwich Research Park, Norwich, Norfolk NR4 7UH, United Kingdom Biotica Technology Limited, Chesterford Research Park, Essex CB10 1XL, U.K., Section of Structural Biology, Chester Beatty Laboratories, Institute of Cancer Research, 237 Fulham Road, London SW3 6JB, U.K., and CompChem Solutions, St. John’s Innovation Centre, Cowley Road, Cambridge CB4 0WS, U.K. Bioprocessing Research Unit, GlaxoWellcome Research and Development, Medicines Research Centre, Gunnels Wood Road, Stevenage, Hertfordshire SG1 2NY, UK Biotica, Chesterford Research Park, Cambridge CB10 1XL, United Kingdom; Department of Molecular Microbiology; John Innes Centre; Norwich Research Park; Norwich NR4 7UH; UK |
Incoming Links
Total number of triples: 106.